share_log

UBS Initiates Coverage on Pacific Biosciences of California With Neutral Rating, $13 Price Target

UBS Initiates Coverage on Pacific Biosciences of California With Neutral Rating, $13 Price Target

瑞銀以中性評級啟動對加州太平洋生物科學的覆蓋率,目標價格為 13 美元
MT Newswires ·  2023/02/02 09:05

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論